TRANSGENE
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-24
TRANSGENE
Equibles does not estimate personal net worth.
Lucy has spoken on 1 earnings call across 1 company, most recently for TRANSGENE on March 24, 2026. TRANSGENE is classified in the Biotechnology industry within the Healthcare sector.
“We will review the progress over 2025 and answer any questions you may have. Before I turn the call over to Alessandro, I'd like to remind everyone that today's discussion contains forward-looking statements, which are subject to multiple risks and uncertainties.”
TRANSGENE
Transcript header (unverified)
TRANSGENE
Biotechnology · Healthcare
2025 Full-year Results
TRANSGENE